Planet 13 Holdings (PLNH) Cash from Investing Activities (2021 - 2026)
Planet 13 Holdings' (PLNH) quarterly Cash from Investing Activities came in at $854829.0 in Q1 2026, up 131.76% year-on-year from $368837.5 in Q1 2025, and down 57.58% on a QoQ basis from $2.0 million in Q4 2025.
Planet 13 Holdings (PLNH) Cash from Investing Activities (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has 6 years of Cash from Investing Activities data on file, last reported at $854829.0 in Q1 2026.
- On a quarterly basis, Cash from Investing Activities rose 131.76% year-over-year to $854829.0 in Q1 2026; TTM through Mar 2026 was $6.1 million, a 271.91% increase from a year earlier, with the FY2025 full-year figure at $2.5 million, up 166.82% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at $854829.0, down from $2.0 million in the prior quarter.
- Over the last five years, Cash from Investing Activities for PLNH reached as high as $5.5 million in Q3 2025 and fell as low as -$7.7 million in Q2 2022.
- Historically, Cash from Investing Activities has averaged -$1.4 million across 5 years, with a median of -$2.4 million in 2023.
- Across the five-year window, Cash from Investing Activities surged 1206.36% in 2024 and tumbled 154.63% in 2025, its largest moves.
- Year by year, Cash from Investing Activities stood at -$1.0 million in 2022, then sank by 128.71% to -$2.4 million in 2023, then declined by 8.44% to -$2.5 million in 2024, then surged by 179.05% to $2.0 million in 2025, then plunged by 57.58% to $854829.0 in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were $854829.0 in Q1 2026, $2.0 million in Q4 2025, and $5.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.55 Bn | 87.69 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 36.00 Bn | 32.26 Bn | 1.97 Bn | 229.00 Mn |
| 3 | Zoetis | 32.59 Bn | 30.65 Bn | 1.62 Bn | -87.00 Mn |
| 4 | Takeda Pharmaceutical | 27.52 Bn | 23.45 Bn | 4.39 Bn | -369.95 Mn |
| 5 | United Therapeutics | 23.07 Bn | 20.91 Bn | 648.10 Mn | 743.70 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.28 Bn | 18.47 Bn | 1.16 Bn | 277.40 Mn |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.47 Bn | 800.70 Mn | -506.20 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -60.00 Mn |
| 10 | Planet 13 Holdings | 39.32 Mn | 23.06 Mn | 9.41 Mn | 854,829.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 854,829.00 |
| Mar 31, 2026 | 854,829.00 |
| Dec 31, 2025 | 2.01 Mn |
| Dec 31, 2025 | 2.01 Mn |
| Sep 30, 2025 | 5.48 Mn |
| Sep 30, 2025 | 5.48 Mn |
| Jun 30, 2025 | -2.28 Mn |
| Jun 30, 2025 | -2.28 Mn |
| Mar 31, 2025 | -2.69 Mn |
| Mar 31, 2025 | -2.69 Mn |
| Dec 31, 2024 | -2.55 Mn |
| Dec 31, 2024 | -2.55 Mn |
| Sep 30, 2024 | -2.46 Mn |
| Sep 30, 2024 | -2.46 Mn |
| Jun 30, 2024 | 4.17 Mn |
| Jun 30, 2024 | 4.17 Mn |
| Mar 31, 2024 | -2.94 Mn |
| Mar 31, 2024 | -2.94 Mn |
| Dec 31, 2023 | -2.35 Mn |
| Dec 31, 2023 | -2.35 Mn |